SGLT2 Inhibitors Post-Heart Transplant: What the Data Show
A 2026 meta-analysis examines SGLT2 inhibitor use in diabetic heart transplant recipients, a population where evidence has been thin and stakes are high.
Highlights
Atrial Fibrillation and Cardio-Kidney-Metabolic Risk: A Systemic Challenge
A new analysis highlights the complex interplay of cardio-kidney-metabolic (CKM) risk factors in patients with atrial fibrillation, underscoring the need for integrated care models. The study points to significant policy and reimbursement challenges in establishing multidisciplinary CKM clinics.
Perilla Oil Nanoemulsion Improves Psoriasis Scores in Mouse Model
A perilla essential oil nanoemulsion reduced erythema, scaling, and inflammatory markers in imiquimod-induced psoriasis, with curcumin co-loading enhancing skin permeation.
Parkinson's Neuroprotection 2025: Three Strategies Under Review
Stem cell therapy, System Xc- pathway modulation, and Ayurvedic add-on regimens are each being evaluated as neuroprotective strategies in Parkinson's disease.
Opportunistic Osteoporosis Screening from CT Scans A Validated Approach?
Using cranial CT scans for opportunistic osteoporosis screening shows promise, but concerns remain. Addressing methodological criticisms is essential for validating this approach in broader clinical practice.
News
Endocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal Risks and Glycemic ControlPsychiatry|Addiction Recovery: A Canadian Perspective on a Global CrisisCardiology|Atrial Fibrillation and Cardio-Kidney-Metabolic Risk: A Systemic ChallengeEndocrinology|What Still Eludes Us in MASH Research?Oncology|ctDNA Liquid Biopsy in Colorectal Cancer: Where the Evidence Sits NowCardiology|TAVI and Aortic Dissection Risk: Is Valve Type a Factor?Cardiology|SGLT2 Inhibitors Post-Heart Transplant: What the Data ShowNephrology|Kidney Disease Diagnosis: The Promise of Urinary ExosomesGeneral Practice|Health Literacy and Lung Cancer Diagnostic DelaysPulmonology|Systemic Sclerosis and Pulmonary Tuberculosis RiskEndocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal RisksGastroenterology|Endoluminal Markers Predict Crohn's Treatment FailureEndocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal Risks and Glycemic ControlPsychiatry|Addiction Recovery: A Canadian Perspective on a Global CrisisCardiology|Atrial Fibrillation and Cardio-Kidney-Metabolic Risk: A Systemic ChallengeEndocrinology|What Still Eludes Us in MASH Research?Oncology|ctDNA Liquid Biopsy in Colorectal Cancer: Where the Evidence Sits NowCardiology|TAVI and Aortic Dissection Risk: Is Valve Type a Factor?Cardiology|SGLT2 Inhibitors Post-Heart Transplant: What the Data ShowNephrology|Kidney Disease Diagnosis: The Promise of Urinary ExosomesGeneral Practice|Health Literacy and Lung Cancer Diagnostic DelaysPulmonology|Systemic Sclerosis and Pulmonary Tuberculosis RiskEndocrinology|SGLT2 Inhibitors in Prader-Willi Syndrome: Weighing Renal RisksGastroenterology|Endoluminal Markers Predict Crohn's Treatment Failure